We are live on ! Find out more
RVLP

RVL Pharmaceuticals plc Ordinary Shares
RVLP

Delisted

RVLP was delisted on the 20th of October, 2023.

Back to rankings

55 hedge funds and large institutions have $25.6M invested in RVL Pharmaceuticals plc Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 16

8% less funds holding

Funds holding: 60 → 55 (-5)

17% less capital invested

Capital invested by funds: $31M → $25.6M (-$5.31M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
55
Holders Change
-5
Holders Change %
-8.33%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
20
Reduced
16
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$2.84M
2
SCM
Sio Capital Management
New York
+$2.13M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.68M
4
Squarepoint
Squarepoint
New York
+$683K
5
Bank of America
Bank of America
North Carolina
+$231K

Top Sellers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
-$2.31M
2
DCM
DG Capital Management
New York
-$2.11M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$734K
4
BFM
Boothbay Fund Management
New York
-$346K
5
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$257K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$2K – – –
PNC Financial Services Group
52
PNC Financial Services Group
Pennsylvania
$2K – – –
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$1K -$6.61K -1,606 -81%
AIG
54
American International Group
New York
$24 +$78 +19 +0.3%
MF
55
Magnetar Financial
Illinois
– -$2.31M -561,978 Closed
DCM
56
DG Capital Management
New York
– -$2.11M -511,063 Closed
BFM
57
Boothbay Fund Management
New York
– -$346K -83,867 Closed
State of Wisconsin Investment Board
58
State of Wisconsin Investment Board
Wisconsin
– -$257K -62,400 Closed
Russell Investments Group
59
Russell Investments Group
United Kingdom
– -$222K -53,973 Closed
SGAM
60
Smith Group Asset Management
Texas
– -$214K -51,890 Closed
QSS
61
Quantitative Systematic Strategies
Florida
– -$107K -25,895 Closed
TI
62
Trexquant Investment
Connecticut
– -$72K -17,467 Closed
CCM
63
CAAS Capital Management
New York
– -$45K -10,977 Closed
Jane Street
64
Jane Street
New York
– -$42K -10,144 Closed
Lazard Asset Management
65
Lazard Asset Management
New York
– -$16K -4,011 Closed
Federated Hermes
66
Federated Hermes
Pennsylvania
– -$14K -3,418 Closed
PAM
67
Panagora Asset Management
Massachusetts
– -$1K -202 Closed
1 2
3

RVLP Hedge Fund Activity: Q1 2021 in Review

55 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q1 2021, worth a combined $25.6M — down 17% from $31M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of RVLP and 8 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 20 added.

The largest buyer was Morgan Stanley, adding an estimated $2.84M. The largest seller was Magnetar Financial, exiting entirely with an estimated $2.31M sold.

  • 55 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q1 2021, down from 60 in Q4 2020.
  • Funds reported $25.6M of RVL Pharmaceuticals plc Ordinary Shares stock for Q1 2021, down 17% quarter-over-quarter.
  • 8 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q1 2021 and 13 closed out, a net change of -5 holders.
  • The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q1 2021 was Morgan Stanley, an estimated $2.84M added.
  • The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q1 2021 was Magnetar Financial, an estimated $2.31M sold.

Based on aggregated 13F filings for Q1 2021.